Zdeněk Linke

1.2k total citations · 1 hit paper
18 papers, 860 citations indexed

About

Zdeněk Linke is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Gastroenterology. According to data from OpenAlex, Zdeněk Linke has authored 18 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Gastroenterology. Recurrent topics in Zdeněk Linke's work include Gastric Cancer Management and Outcomes (7 papers), Gastrointestinal Tumor Research and Treatment (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Zdeněk Linke is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Gastrointestinal Tumor Research and Treatment (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Zdeněk Linke collaborates with scholars based in Czechia, Slovakia and Malaysia. Zdeněk Linke's co-authors include Jozef Šufliarský, Lukáš Plank, Magnús K. Magnússon, Jón G. Jónasson, Toshirou Nishida, Chiara Braconi, Andrea Bordoni, Piotr Rutkowski, Heikki Joensuu and Massimo Federico and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Zdeněk Linke

16 papers receiving 847 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts

2011 673 citations Heikki Joensuu, Aki Vehtari et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Zdeněk Linke

Since Specialization

Citations

This map shows the geographic impact of Zdeněk Linke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zdeněk Linke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zdeněk Linke more than expected).

Fields of papers citing papers by Zdeněk Linke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zdeněk Linke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zdeněk Linke. The network helps show where Zdeněk Linke may publish in the future.

Co-authorship network of co-authors of Zdeněk Linke

This figure shows the co-authorship network connecting the top 25 collaborators of Zdeněk Linke. A scholar is included among the top collaborators of Zdeněk Linke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zdeněk Linke. Zdeněk Linke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Indications for venous access in oncology – recommendations of national professional societies and current state in the Czech Republic 2021 ·Klinicka onkologie ·(unknown), J Charvát, (unknown), (unknown), Zdeněk Linke, (unknown), (unknown), Pavel Michálek, (unknown), (unknown), (unknown), (unknown), (unknown), Martina Douglas	1
2	Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 Patients 2020 ·SHILAP Revista de lepidopterología ·Alena Novakova-Jiresova, Kateřina Kopečková, Ludmila Boublíková, (unknown), Bohuslav Melichar, Luboš Petruželka, Jindřich Fínek, Ondřej Fiala, (unknown), (unknown), Zdeněk Linke, (unknown), Jana Prausová, Tomáš Büchler	1
3	<p>Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 Patients</p> 2020 ·Cancer Management and Research ·Alena Novakova-Jiresova, Kateřina Kopečková, Ludmila Boublíková, (unknown), Bohuslav Melichar, Luboš Petruželka, Jindřich Fínek, Ondřej Fiala, (unknown), (unknown), Zdeněk Linke, Igor Kišš, Jana Prausová, Tomáš Büchler	9
4	Gastric tumors in children: single-center study with emphasis on treatment of repeated recurrence 2020 ·Pediatric Surgery International ·(unknown), J Šnajdauf, (unknown), Barbora Frýbová, Karel Švojgr, Zdeněk Linke, Vladimír Mixa, Roman Kodet, Martin Kynčl, Michal Rygl	3
5	Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study 2020 ·Cancers ·Ian Chau, Marwan Fakih, Pilar García‐Alfonso, Zdeněk Linke, Ana Ruiz‐Casado, (unknown), (unknown), Marina Celanovic, Thomas H. Cartwright	13
6	Gastrointestinal stromal tumors – Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects 2019 ·Pathology - Research and Practice ·(unknown), Zdeněk Linke, Markéta Kalinová, Lenka Krsková, (unknown), (unknown), Aleš Vícha, Roman Kodet	17
7	Phase 2 study results of murlentamab, a monoclonal antibody targeting the Anti-Mullerian-Hormone-Receptor II (AMHRII), acting through Tumor-Associated Macrophage engagement in advanced/metastatic colorectal cancers 2019 ·Annals of Oncology ·Eric Van Cutsem, Bohuslav Melichar, Marc Van den Eynde, Jana Prausová, Karen Geboes, Jeroen Dekervel, (unknown), (unknown), Zdeněk Linke, Nathalie Van Acker, (unknown), G. R. Noel, (unknown), Jean‐Marc Barret, (unknown), Isabelle Tabah-Fisch	5
8	Gastrointestinal stromal tumors - quantitative detection of the Ki-67, TPX2, TOP2A, and hTERT telomerase subunit mRNA levels to determine proliferation activity and a potential for aggressive biological behavior 2016 ·Neoplasma ·(unknown), (unknown), Lenka Krsková, Markéta Kalinová, Zdeněk Linke, Roman Kodet	2
9	Treatment of gastrointestinal stromal tumour 2016 ·Zdeněk Linke	0
10	P-153 Regorafenib in the real-life clinical practice: data from the czech registry 2016 ·Annals of Oncology ·Tomáš Büchler, Zbyněk Bortlíček, Karel Hejduk, Bohuslav Melichar, Petra Pokorná, Zdeněk Linke, Luboš Petruželka, Jindřich Fínek, Jana Prausová, Kateřina Kubáčková	0
11	Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry 2016 ·Targeted Oncology ·Kateřina Kopečková, Tomáš Büchler, Zbyněk Bortlíček, Karel Hejduk, (unknown), Bohuslav Melichar, Petra Pokorná, Jiří Tomášek, Zdeněk Linke, Luboš Petruželka, Igor Kišš, Jana Prausová	18
12	Bevacizumab with chemotherapy in patients with KRAS wild-type metastatic colorectal cancer: Czech registry data 2015 ·Future Oncology ·Kateřina Kubáčková, Zbyněk Bortlíček, (unknown), Zdeněk Linke, Petra Pokorná, Rostislav Vyzula, Jana Prausová	2
13	Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry 2014 ·Targeted Oncology ·(unknown), Kateřina Kubáčková, Zbyněk Bortlíček, Tomáš Pavlík, Bohuslav Melichar, Zdeněk Linke, Petra Pokorná, Rostislav Vyzula, Jana Prausová, Tomáš Büchler	6
14	Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts breakdown → 2011 ·The Lancet Oncology ·Heikki Joensuu, Aki Vehtari, Jaakko Riihimäki, Toshirou Nishida, Sonja E. Steigen, (unknown), Lukáš Plank, Bengt Nilsson, Claudia Cirilli, Chiara Braconi, Andrea Bordoni, Magnús K. Magnússon, Zdeněk Linke, Jozef Šufliarský, Massimo Federico, Jón G. Jónasson, Angelo Paolo Dei Tos, Piotr Rutkowski	673
15	FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer 2009 ·Clinical Immunology ·Daniela Rožková, (unknown), Jitka Fučíková, Jan Lašťovička, (unknown), (unknown), (unknown), Jana Prausová, Zdeněk Linke, (unknown), Anna Šedivá, Radek Špíšek, Jiřina Bartůňková	28
16	A whole population study of gastrointestinal stromal tumors in the Czech Republic and Slovakia 2009 ·Neoplasma ·Petr Brabec, Jozef Šufliarský, Zdeněk Linke, Lukáš Plank, Marcela Mrhalová, Tomáš Pavlík, (unknown), Jakub Gregor	19
17	Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients—single center experience 2006 ·Supportive Care in Cancer ·J Charvát, Zdeněk Linke, (unknown), Jana Prausová	55
18	Gastric Cancer in Young Patients — Is There Any Hope for Them ? 2004 ·Acta chirurgica Belgica ·(unknown), (unknown), Jeffrey S. Hoch, Zdeněk Linke, Radek Pádr	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact